Aware Super Pty Ltd as trustee of Aware Super lifted its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 424.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,099 shares of the financial services provider’s stock after buying an additional 38,115 shares during the quarter. Aware Super Pty Ltd as trustee of Aware Super’s holdings in CME Group were worth $12,981,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Heartland Bank & Trust Co purchased a new stake in CME Group in the 1st quarter worth approximately $377,000. Catalyst Capital Advisors LLC boosted its holdings in shares of CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after purchasing an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. acquired a new stake in shares of CME Group during the first quarter worth $367,000. Fulcrum Equity Management purchased a new stake in shares of CME Group in the first quarter valued at $258,000. Finally, AIA Group Ltd increased its stake in CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after purchasing an additional 2,510 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
Insider Buying and Selling
In related news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,043 shares of company stock worth $3,527,956. Company insiders own 0.30% of the company’s stock.
CME Group Trading Up 0.4%
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the business earned $2.56 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 48.40%.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CME. TD Cowen raised their price target on CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a report on Thursday, October 9th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $283.71.
Get Our Latest Stock Analysis on CME Group
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Financial Services Stocks Investing
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- 3 Best Fintech Stocks for a Portfolio Boost
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Stock Dividend Cuts Happen Are You Ready?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.